Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

January 31, 2010

Conditions
Cervical Cancer
Interventions
DRUG

topotecan hydrochloride

Trial Locations (27)

27710

Duke Comprehensive Cancer Center, Durham

33805

Lakeland Regional Cancer Center at Lakeland Regional Medical Center, Lakeland

35294

Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham

39216

University of Mississippi Cancer Clinic, Jackson

39581

Regional Cancer Center at Singing River Hospital, Pascagoula

43222

Mount Carmel Health - West Hospital, Columbus

45267

Charles M. Barrett Cancer Center at University Hospital, Cincinnati

45409

David L. Rike Cancer Center at Miami Valley Hospital, Dayton

48073

William Beaumont Hospital - Royal Oak Campus, Royal Oak

63110

Saint Louis University Cancer Center, St Louis

68114

Methodist Estabrook Cancer Center, Omaha

73104

Oklahoma University Cancer Institute, Oklahoma City

74104

Cancer Care Associates - Midtown Tulsa, Tulsa

90027

Kaiser Permanente Medical Center - Los Angeles, Los Angeles

91342

Olive View - UCLA Medical Center Foundation, Sylmar

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

06102-5037

Helen and Harry Gray Cancer Center at Hartford Hospital, Hartford

06050

George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus, New Britain

06520-8028

Yale Cancer Center, New Haven

31403-3089

Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah

60637-1470

University of Chicago Cancer Research Center, Chicago

46202-5289

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

52242-1002

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

43210-1240

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus

43214-3998

Riverside Methodist Hospital Cancer Care, Columbus

02905

Women and Infants Hospital of Rhode Island, Providence

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00087126 - Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer | Biotech Hunter | Biotech Hunter